POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1.
Liu G, Jin K, Liu Z, Su X, Xu Z, Li B, Xu J, Chang Y, Wang Y, Zhu Y, Xu L, Xu J, Wang Z, Liu H, Zhang W.
Liu G, et al. Among authors: xu l, xu z, xu j.
Cancer Med. 2024 Feb;13(4):e6962. doi: 10.1002/cam4.6962.
Cancer Med. 2024.
PMID: 38457207
Free PMC article.